Telangana Government Unveils Draft CURE Bill 2026, Proposing Historic Overhaul of Hyderabad’s Urban Governance

Date:

Share post:

In a major step toward realizing its ambitious “Telangana Rising 2047” vision, the Government of Telangana has officially released the draft **Telangana Core Urban Region (Integrated Governance) Bill, 2026(the CURE Bill) for public consultation. Aimed at modernizing urban management, the landmark legislation proposes replacing the decades-old Greater Hyderabad Municipal Corporation (GHMC) Act of 1955 to support a metropolitan population that has swelled to 1.3 crore citizens.

The CURE Bill outlines progressive reforms to transform Hyderabad into a world-class economic engine. Key features include the transition to a capital value-based property tax system, a structured escalation process ensuring faster building layout approvals, and a single-window digital portal introducing a “Unified Utility Bill” for streamlined citizen services.

Furthermore, the bill charts a bold path for economic growth by introducing a 24-Hour Economy Vision through designated “Night Economy Zones.” It also mandates the first-ever high-level dedicated Food Safety Committee and establishes stringent climate action guidelines for urban disaster management and lake conservation.

Chief Minister A. Revanth Reddy’s administration invites stakeholders and the public to review the framework, steering the capital region toward an equitable, sustainable, and highly competitive future.

Written by: Pragna Biswas

Graphics by: Pragna Biswas

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...